Off-label prescribing: In search of a reasonable patient-centered approach

Ben A Rich

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


This commentary relates to an article entitled "Off-Label Prescribing of Medications for Pain: Maintaining Optimal Care at an Intersection of Law, Public Policy, and Ethics," which appears in the same journal issue. Off-label prescribing and off-label marketing of drugs are differentiated. Vulnerability of pain patients with off-label prescribing is noted as is the lack of data on benefits and risks of the practice. The influence of the pharmaceutical industry in off-label prescribing is discussed. A lack of transparency when communicating with patients about off-label drug use is a concern.

Original languageEnglish (US)
Pages (from-to)131-133
Number of pages3
JournalJournal of Pain and Palliative Care Pharmacotherapy
Issue number2
StatePublished - Jun 2012


  • Ethics
  • Law
  • Marketing
  • Off-label
  • Policy
  • Prescribing

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Pharmacology (medical)


Dive into the research topics of 'Off-label prescribing: In search of a reasonable patient-centered approach'. Together they form a unique fingerprint.

Cite this